Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-4-4
pubmed:abstractText
Most patients undergoing allogeneic marrow transplantation (alloBMT) require transfusions of RBCs. A retrospective analysis was performed to evaluate the utilization and risk factors for RBC transfusions including age and sex of recipient, HLA matching between donor and recipient, disease status at time of BMT, the occurrence of GVHD, ABO blood group compatibility, the source of progenitor cells and the Hb level before BMT (PT-Hb).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0041-1132
pubmed:author
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
373-82
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12675724-Adolescent, pubmed-meshheading:12675724-Adult, pubmed-meshheading:12675724-Aged, pubmed-meshheading:12675724-Blood Group Incompatibility, pubmed-meshheading:12675724-Bone Marrow Transplantation, pubmed-meshheading:12675724-Erythrocyte Transfusion, pubmed-meshheading:12675724-Female, pubmed-meshheading:12675724-Graft vs Host Disease, pubmed-meshheading:12675724-Hemoglobins, pubmed-meshheading:12675724-Humans, pubmed-meshheading:12675724-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:12675724-Male, pubmed-meshheading:12675724-Middle Aged, pubmed-meshheading:12675724-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:12675724-Retrospective Studies, pubmed-meshheading:12675724-Risk Factors, pubmed-meshheading:12675724-Sex Characteristics, pubmed-meshheading:12675724-Time Factors, pubmed-meshheading:12675724-Tissue Donors, pubmed-meshheading:12675724-Transplantation, Homologous
pubmed:year
2003
pubmed:articleTitle
RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival.
pubmed:affiliation
Hematology Division, London Health Sciences Center, University of Western Ontario, Canada. anargyros.xenocosta@lhsc.on.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't